Ganessan Kichenadasse

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Topics

Radical Prostatectomy

Top Venues

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

British journal of cancer

Prostate cancer and prostatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Geraldine Laven-Law, Ganessan Kichenadasse, Graeme Paul Young, Erin Leigh Symonds, Jean M Winter
BCAT1 , IKZF1 and SEPT9 : methylated DNA biomarkers for detection of pan-gastrointestinal adenocarcinomas. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 29 (4) (2024)
Razia Rahman, Muhammed H Rahaman, Adrienne R Hanson, Nicholas Choo, Jianling Xie, Scott L Townley, Raj Shrestha, Ramin Hassankhani, Saiful Islam, Susanne Ramm, Kaylene J Simpson, Gail P Risbridger, Giles Best, Margaret M Centenera, Steven P Balk, Ganessan Kichenadasse, Renea A Taylor, Lisa M Butler, Wayne D Tilley, Simon J Conn, Mitchell G Lawrence, Shudong Wang, Luke A Selth
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer. British journal of cancer (2024)
Geraldine Laven-Law, Ganessan Kichenadasse, Graeme Paul Young, Erin Leigh Symonds, Jean M Winter
BCAT1 , IKZF1 and SEPT9 : methylated DNA biomarkers for detection of pan-gastrointestinal adenocarcinomas. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 29 (4) (2024)
Peter S Grimison, Antony Mersiades, Adrienne Kirby, Annette Tognela, Ian N Olver, Rachael Lisa Morton, Paul Haber, Anna Walsh, Yvonne Lee, Ehtesham Abdi, Stephen Della-Fiorentina, Morteza Aghmesheh, Peter Fox, Karen Briscoe, Jasotha Sanmugarajah, Gavin Marx, Ganessan Kichenadasse, Helen Wheeler, Matthew Chan, Jenny Shannon, Craig Gedye, Stephen D Begbie, R John Simes, Martin R Stockler
Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Geraldine Laven-Law, Ganessan Kichenadasse, Graeme Paul Young, Erin Leigh Symonds, Jean M Winter
BCAT1 , IKZF1 and SEPT9 : methylated DNA biomarkers for detection of pan-gastrointestinal adenocarcinomas. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 29 (4) (2024)
Geraldine Laven-Law, Ganessan Kichenadasse, Graeme Paul Young, Erin Leigh Symonds, Jean M Winter
BCAT1 , IKZF1 and SEPT9 : methylated DNA biomarkers for detection of pan-gastrointestinal adenocarcinomas. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2024)
Jason D Lickliter, Jeremy Ruben, Ganessan Kichenadasse, Ross R Jennens, Cecelia Gzell, Ralph P Mason, Heling Zhou, Jennifer Becker, Evan C Unger, Baldassarre Stea
Dodecafluoropentane Emulsion as a Radiosensitizer in Glioblastoma Multiforme. Cancer research communications 3 (8) (2023)
Ashley M Hopkins, Jessica M Logan, Ganessan Kichenadasse, Michael J Sorich
Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift. JNCI cancer spectrum 7 (2) (2023)
Ganessan Kichenadasse, Bogda Koczwara, Christos S Karapetis
Re: Workforce challenges across Victorian medical oncology services: review consultations and workload. Internal medicine journal 53 (6) (2023)
Brett W Stringer, Manam Inushi De Silva, Zarina Greenberg, Alejandra Noreña Puerta, Robert J Adams, Bridget Milky, Michael Zabolocki, Mark van den Hurk, Lisa M Ebert, Christine Fairly Bishop, Simon J Conn, Ganessan Kichenadasse, Michael Z Michael, Rebecca J Ormsby, Santosh Poonoose, Cedric Bardy
Human cerebrospinal fluid affects chemoradiotherapy sensitivities in tumor cells from patients with glioblastoma. Science advances 9 (43) (2023)
Mrunal D Hiwase, Alex Jay, Norma B Bulamu, Johnathan Teh, Felix Paterson, Ganessan Kichenadasse, Andrew D Vincent, Michael O'Callaghan, null null
Evaluation of selective bone scan staging in prostate cancer - external validation of current strategies and decision-curve analysis. Prostate cancer and prostatic diseases 25 (2) (2022)
Sheau Wen Lok, Richard De Boer, Sally Baron-Hay, Peter Button, Bianca Devitt, Benjamin C Forster, Peter Fox, Michael Harold, Sahisha Ketheeswaran, Ganessan Kichenadasse, Belinda E Kiely, Gavin Marx, Louise Nott, Laura Pellegrini, Ali Tafreshi, Peter Gibbs
Pertuzumab study in the neoadjuvant setting for HER2-positive nonmetastatic breast cancer in Australia (PeRSIA). International journal of cancer 152 (2) (2022)
Misa Matsuyama, Mythily Sachchithananthan, Robyn Leonard, Michael Besser, Anna K Nowak, Donna Truran, Claire M Vajdic, John R Zalcberg, Hui Kong Gan, Craig Gedye, Winny Varikatt, Eng-Siew Koh, Ganessan Kichenadasse, Hao-Wen Sim, Nicholas G Gottardo, Desma Spyridopoulos, Rosalind L Jeffree
What matters for people with brain cancer? Selecting clinical quality indicators for an Australian Brain Cancer Registry. Neuro-oncology practice 9 (1) (2021)
Ashley M Hopkins, Ganessan Kichenadasse, Ross A McKinnon, Ahmad Y Abuhelwa, Jessica M Logan, Sarah Badaoui, Christos S Karapetis, Andrew Rowland, Michael J Sorich
Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150. British journal of cancer (2021)
Ashley M Hopkins, Ganessan Kichenadasse, Ahmad Y Abuhelwa, Ross A McKinnon, Andrew Rowland, Michael J Sorich
Reply to Auclin et al. Comment on "Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13, 1176". Cancers 13 (15) (2021)
Alwin Soo, Michael E O'Callaghan, Tina Kopsaftis, Sina Vatandoust, Kim L Moretti, Ganessan Kichenadasse
PSA response to antiandrogen withdrawal: a systematic review and meta-analysis. Prostate cancer and prostatic diseases 24 (3) (2021)
Andreas Obermair, Philip Beale, Clare L Scott, Victoria Beshay, Ganessan Kichenadasse, Bryony Simcock, James L Nicklin, Yeh Chen Lee, Paul Andrew Cohen, Tarek M Meniawy
Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 2020. Journal of gynecologic oncology 32 (6) (2021)
Ashley M Hopkins, Bradley D Menz, Michael D Wiese, Ganessan Kichenadasse, Howard Gurney, Ross A McKinnon, Andrew Rowland, Michael J Sorich
Nuances to precision dosing strategies of targeted cancer medicines. Pharmacology research & perspectives 8 (4) (2021)
Jason D Lickliter, Mark Voskoboynik, Linda Mileshkin, Hui K Gan, Ganessan Kichenadasse, Kathy Zhang, Maggie Zhang, Zhiyu Tang, Michael Millward
Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours. British journal of cancer (2021)
Holly E L Evans, Cynthia C Forbes, Daniel A Galvão, Corneel Vandelanotte PhD, Robert U Newton, Gary Allen Wittert, Suzanne K Chambers, Andrew D Vincent, Ganessan Kichenadasse, Danielle Girard, Nicholas Brook, Camille Elizabeth Short
Usability, Acceptability, and Safety Analysis of a Computer-Tailored Web-Based Exercise Intervention (ExerciseGuide) for Individuals With Metastatic Prostate Cancer: Multi-Methods Laboratory-Based Study. JMIR cancer 7 (3) (2021)
Natansh D Modi, Jin Quan Eugene Tan, Andrew Rowland, Bogda Koczwara, Ahmad Y Abuhelwa, Ganessan Kichenadasse, Ross A McKinnon, Michael D Wiese, Michael J Sorich, Ashley M Hopkins
The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data. NPJ breast cancer 7 (1) (2021)
Jermaine I G Coward, Minal A Barve, Ganessan Kichenadasse, Kathleen N Moore, Paul R Harnett, Daniel Berg, James S Garner, Don S Dizon
Maximum Tolerated Dose and Anti-Tumor Activity of Intraperitoneal Cantrixil (TRX-E-002-1) in Patients with Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: Phase I Study Results. Cancers 13 (13) (2021)
Holly E L Evans, Cynthia C Forbes, Corneel Vandelanotte PhD, Daniel A Galvão, Robert U Newton, Gary Allen Wittert, Suzanne K Chambers, Ganessan Kichenadasse, Nicholas Brook, Danielle Girard, Camille Elizabeth Short
Examining the Priorities, Needs and Preferences of Men with Metastatic Prostate Cancer in Designing a Personalised eHealth Exercise Intervention. International journal of behavioral medicine 28 (4) (2020)
Ganessan Kichenadasse, Jim Henry Hughes, John O Miners, Arduino A Mangoni, Andrew Rowland, Ashley M Hopkins, Michael J Sorich
Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced melanoma. Cancer chemotherapy and pharmacology 85 (3) (2019)